Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY23.00 CNY
Change Today 0.00 / 0.00%
Volume 0.0
002020 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang jingxin pharmaceu-a (002020) Snapshot

Open
CNY25.00
Previous Close
CNY23.00
Day High
CNY25.00
Day Low
CNY22.82
52 Week High
08/18/15 - CNY31.30
52 Week Low
12/30/14 - CNY15.93
Market Cap
6.6B
Average Volume 10 Days
10.5M
EPS TTM
CNY0.50
Shares Outstanding
286.5M
EX-Date
07/7/15
P/E TM
46.2x
Dividend
CNY0.15
Dividend Yield
0.65%
Current Stock Chart for ZHEJIANG JINGXIN PHARMACEU-A (002020)

Related News

No related news articles were found.

zhejiang jingxin pharmaceu-a (002020) Related Businessweek News

No Related Businessweek News Found

zhejiang jingxin pharmaceu-a (002020) Details

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells finished dosage forms, APIs, and Chinese herbal drugs in China. It focuses on novelty and generic drugs for anti-infective, cardiovascular, and cerebrovascular diseases, including hypertension, hyperlipemia, hyperglycemia, and antiplatelet coagulating; and central nervous system, such as antidepressant, antipsychotic, antiparkinsonian, anti-alzheimer's disease, sedative-hypnotic, and anticonvulsant. The company’s finished dosage forms include tablets, capsules, injections, and powders for injections in the areas of antilipemic, antidiabetic, antihypertensive, antidepressant, gastrointestinal promotion, antihistamine, cerebrovarscular, quitting smoking assistant, anti-inflammatory analgesic, and antibiotics. It also offers contract manufacturing services. Zhejiang Jingxin Pharmaceutical Co., Ltd. exports its products to South-East Asia, South Asia, Latin America, and Europe. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1974 and is headquartered in Xinchang, China.

Founded in 1974

zhejiang jingxin pharmaceu-a (002020) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang jingxin pharmaceu-a (002020) Key Developments

Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report First Half, 2015 Results on Aug 25, 2015

Zhejiang Jingxin Pharmaceutical Co., Ltd. announced that they will report first half, 2015 results on Aug 25, 2015

Zhejiang Jingxin Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Aug 12, 2015

Zhejiang Jingxin Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Aug 12, 2015., at 14:00 China Standard Time. Agenda: To consider compliance with relevant laws and regulations of the company's asset purchase via share offering and cash payment and matching fund raising; to consider scheme for connected transaction regarding assets purchase via share offering and cash payment and matching fund raising; to consider the assets purchase via share offering and cash payment and raising matching fund is in compliance with the 4th article in the Provisions on Several Issues Concerning the Regulation of Major Assets Restructuring by Listed Companies; to consider the asset purchase via share offering and cash payment and raising matching fund do not constitute major assets restructuring; to consider the asset purchase via share offering and cash payment and matching fund raising constitute connected transaction; to consider to sign conditional agreements on assets purchase via share offering and cash payment, on profit compensation and share subscription; and to consider other agenda.

Zhejiang Jingxin Pharmaceutical Co., Ltd Announces 2014 Final Distribution, Payable on 07 July 2015

Zhejiang Jingxin Pharmaceutical Co., Ltd. announced 2014 final distribution of CNY 1.50 per 10 class A shares (tax included), payable on 07 July 2015 to the record holders of 06 July 2015. Ex-date is 07 July 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002020:CH CNY23.00 CNY 0.00

002020 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002020.
View Industry Companies
 

Industry Analysis

002020

Industry Average

Valuation 002020 Industry Range
Price/Earnings 44.9x
Price/Sales 4.8x
Price/Book 4.4x
Price/Cash Flow 44.9x
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG JINGXIN PHARMACEU-A, please visit www.jingxinpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.